Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
ACS Chemical Neuroscience
|
September 20, 2011
Recent advances in the design and development of novel negative allosteric modulators of mGlu(5)
Kyle A Emmitte
Expert Opinion on Therapeutic Patents
|
January 10, 2017
mGlu<sub>5</sub> negative allosteric modulators: a patent review (2013 - 2016)
Kyle A Emmitte
Expert Opinion on Therapeutic Patents
|
January 24, 2013
mGlu5 negative allosteric modulators: a patent review (2010-2012)
Kyle A Emmitte
Current Opinion in Drug Discovery & Development
|
June 30, 2009
Recent progress in the discovery and development of negative allosteric modulators of mGluR5
Craig W Lindsley, Kyle A Emmitte
Expert Opinion on Therapeutic Patents
|
May 16, 2025
An updated patent review of small molecule KCNT1 inhibitors (2022-2024)
Paul K Peprah, Kyle A Emmitte
Expert Opinion on Therapeutic Patents
|
March 15, 2021
Negative allosteric modulators of group II metabotropic glutamate receptors: A patent review (2015 - present)
Alshaima'a M Qunies, Kyle A Emmitte
Pharmaceutical Patent Analyst
|
April 4, 2022
Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies
Alshaima'a M Qunies, Kyle A Emmitte
Future Medicinal Chemistry
|
May 6, 2026
A review of recent efforts directed toward the discovery of small molecule modulators of KCNT1 channels
Paul K Peprah, Kyle A Emmitte
ACS Omega
|
August 11, 2025
I‑GAT: Interpretable Graph Attention Networks for Ligand Optimization
Ezek Mathew, Kyle A Emmitte, Jin Liu
Organic Letters
|
August 27, 2005
A convergent coupling strategy for the formation of polycyclic ethers: stereoselective synthesis of the BCDE fragment of brevetoxin A
Michael T Crimmins, Patrick J McDougall, Kyle A Emmitte
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
ACS Chemical Neuroscience
|
September 20, 2011
Recent advances in the design and development of novel negative allosteric modulators of mGlu(5)
Kyle A Emmitte
Expert Opinion on Therapeutic Patents
|
January 10, 2017
mGlu<sub>5</sub> negative allosteric modulators: a patent review (2013 - 2016)
Kyle A Emmitte
Expert Opinion on Therapeutic Patents
|
January 24, 2013
mGlu5 negative allosteric modulators: a patent review (2010-2012)
Kyle A Emmitte
Current Opinion in Drug Discovery & Development
|
June 30, 2009
Recent progress in the discovery and development of negative allosteric modulators of mGluR5
Craig W Lindsley, Kyle A Emmitte
Expert Opinion on Therapeutic Patents
|
May 16, 2025
An updated patent review of small molecule KCNT1 inhibitors (2022-2024)
Paul K Peprah, Kyle A Emmitte
Expert Opinion on Therapeutic Patents
|
March 15, 2021
Negative allosteric modulators of group II metabotropic glutamate receptors: A patent review (2015 - present)
Alshaima'a M Qunies, Kyle A Emmitte
Pharmaceutical Patent Analyst
|
April 4, 2022
Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies
Alshaima'a M Qunies, Kyle A Emmitte
Future Medicinal Chemistry
|
May 6, 2026
A review of recent efforts directed toward the discovery of small molecule modulators of KCNT1 channels
Paul K Peprah, Kyle A Emmitte
ACS Omega
|
August 11, 2025
I‑GAT: Interpretable Graph Attention Networks for Ligand Optimization
Ezek Mathew, Kyle A Emmitte, Jin Liu
Organic Letters
|
August 27, 2005
A convergent coupling strategy for the formation of polycyclic ethers: stereoselective synthesis of the BCDE fragment of brevetoxin A
Michael T Crimmins, Patrick J McDougall, Kyle A Emmitte
Page
of 7